Source:http://linkedlifedata.com/resource/pubmed/id/15251130
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2004-7-14
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1471-4892
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
368-71
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15251130-Animals,
pubmed-meshheading:15251130-Humans,
pubmed-meshheading:15251130-Inflammation,
pubmed-meshheading:15251130-Interleukin-1,
pubmed-meshheading:15251130-Interleukin-15,
pubmed-meshheading:15251130-Interleukin-6,
pubmed-meshheading:15251130-Tumor Necrosis Factor-alpha
|
pubmed:year |
2004
|
pubmed:articleTitle |
New approaches to therapeutic immunomodulation for immune-mediated inflammatory disorders.
|
pubmed:publicationType |
Editorial
|